We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Calyxt, Inc. (“Calyxt” or the “Company”) (NASDAQ:CLXT), in connection with the proposed acquisition of the Company by Cibus (“Cibus”). Under the terms of the merger agreement, the Company will issue shares of its common stock to Cibus shareholders in an exchange ratio such that upon completion of the merger, Calyxt shareholders will only own approximately 5% of the newly combined company while Cibus shareholders will own 95%.

Weiss Law is investigating whether (i) Calyxt’s board of directors acted in the best interests of Company shareholders in agreeing to the proposed transaction, (ii) the merger consideration adequately compensates Calyxt’s shareholders, and (iii) all information regarding the sales process and valuation of the transaction will be fully and fairly disclosed.